Asiatic acid
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Asiatic acid
- DrugBank Accession Number
- DB14054
- Background
From Centella asiatica and other plants; shows a variety of bioactivities.
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 488.6991
Monoisotopic: 488.350174646 - Chemical Formula
- C30H48O5
- Synonyms
- Dammarolic acid
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Centella Scar Ylang Ylang Asiatic acid (0.045 g/15g) + Asiaticoside (0.06 g/15g) + Madecassic acid (0.045 g/15g) Ointment Topical NoTS Co.,Ltd 2016-12-01 2018-12-01 US Karatica Im Cica Essence Pack Asiatic acid (0.01 g/100mL) + Asiaticoside (0.01 g/100mL) + Madecassic acid (0.01 g/100mL) + Madecassoside (0.01 g/100mL) Liquid Topical Karatica Co., Ltd 2019-08-17 Not applicable US Troiareuke Acsen Recovery Asiatic acid (0.008 g/25mL) + Asiaticoside (0.009 g/25mL) + Madecassic acid (0.008 g/25mL) Cream Topical Mk Universal Inc. 2018-05-01 2018-12-01 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Centella Scar Ylang Ylang Asiatic acid (0.045 g/15g) + Asiaticoside (0.06 g/15g) + Madecassic acid (0.045 g/15g) Ointment Topical NoTS Co.,Ltd 2016-12-01 2018-12-01 US Karatica Im Cica Essence Pack Asiatic acid (0.01 g/100mL) + Asiaticoside (0.01 g/100mL) + Madecassic acid (0.01 g/100mL) + Madecassoside (0.01 g/100mL) Liquid Topical Karatica Co., Ltd 2019-08-17 Not applicable US Troiareuke Acsen Recovery Asiatic acid (0.008 g/25mL) + Asiaticoside (0.009 g/25mL) + Madecassic acid (0.008 g/25mL) Cream Topical Mk Universal Inc. 2018-05-01 2018-12-01 US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 9PA5A687X5
- CAS number
- 464-92-6
- InChI Key
- JXSVIVRDWWRQRT-UYDOISQJSA-N
- InChI
- InChI=1S/C30H48O5/c1-17-9-12-30(25(34)35)14-13-28(5)19(23(30)18(17)2)7-8-22-26(3)15-20(32)24(33)27(4,16-31)21(26)10-11-29(22,28)6/h7,17-18,20-24,31-33H,8-16H2,1-6H3,(H,34,35)/t17-,18+,20-,21-,22-,23+,24+,26+,27+,28-,29-,30+/m1/s1
- IUPAC Name
- (1S,2R,4aS,6aS,6bR,8aR,9R,10R,11R,12aR,12bR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid
- SMILES
- [H][C@@]12CC[C@]3(C)[C@]([H])(CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@@]5(CC[C@@]34C)C(O)=O)[C@@]1(C)C[C@@H](O)[C@H](O)[C@@]2(C)CO
References
- General References
- Not Available
- External Links
- KEGG Compound
- C08617
- ChemSpider
- 106361
- BindingDB
- 50241487
- 1551574
- ChEBI
- 2873
- ChEMBL
- CHEMBL404313
- ZINC
- ZINC000008221271
- PDBe Ligand
- 0AS
- PDB Entries
- 2qn1
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Ointment Topical Liquid Topical Cream Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0114 mg/mL ALOGPS logP 4.81 ALOGPS logP 4.23 Chemaxon logS -4.6 ALOGPS pKa (Strongest Acidic) 4.74 Chemaxon pKa (Strongest Basic) -2.8 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 97.99 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 136.83 m3·mol-1 Chemaxon Polarizability 56.63 Å3 Chemaxon Number of Rings 5 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created at June 12, 2018 16:04 / Updated at June 12, 2020 16:53